0 false false false false false false false true false false true false false false false false false No description of principal activity 2022-08-01 Sage Accounts Production Advanced 2023 - FRS102_2023 100 100 100 xbrli:pure xbrli:shares iso4217:GBP 07135184 2022-08-01 2023-07-31 07135184 2023-07-31 07135184 2022-07-31 07135184 2021-08-01 2022-07-31 07135184 2022-07-31 07135184 2021-07-31 07135184 bus:RegisteredOffice 2022-08-01 2023-07-31 07135184 bus:LeadAgentIfApplicable 2022-08-01 2023-07-31 07135184 bus:Director1 2022-08-01 2023-07-31 07135184 bus:Director2 2022-08-01 2023-07-31 07135184 core:WithinOneYear 2023-07-31 07135184 core:WithinOneYear 2022-07-31 07135184 core:ShareCapital 2023-07-31 07135184 core:ShareCapital 2022-07-31 07135184 core:RetainedEarningsAccumulatedLosses 2023-07-31 07135184 core:RetainedEarningsAccumulatedLosses 2022-07-31 07135184 core:CostValuation core:Non-currentFinancialInstruments 2023-07-31 07135184 core:Non-currentFinancialInstruments 2023-07-31 07135184 core:Non-currentFinancialInstruments 2022-07-31 07135184 bus:SmallEntities 2022-08-01 2023-07-31 07135184 bus:AuditExemptWithAccountantsReport 2022-08-01 2023-07-31 07135184 bus:SmallCompaniesRegimeForAccounts 2022-08-01 2023-07-31 07135184 bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31 07135184 bus:FullAccounts 2022-08-01 2023-07-31
COMPANY REGISTRATION NUMBER: 07135184
FRANCIS LAM MEDICAL PRACTICE LTD
FILLETED UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 July 2023
FRANCIS LAM MEDICAL PRACTICE LTD
FINANCIAL STATEMENTS
YEAR ENDED 31 JULY 2023
Contents
Page
Officers and professional advisers
1
Statement of financial position
2
Notes to the financial statements
4
FRANCIS LAM MEDICAL PRACTICE LTD
OFFICERS AND PROFESSIONAL ADVISERS
The board of directors
Mr F Lam
Ms J Lim
Registered office
Lynton House
7-12 Tavistock Square
London
WC1H 9BQ
Accountants
TC BSG Valentine Limited
Accountants
Lynton House
7-12 Tavistock Square
London
WC1H 9BQ
FRANCIS LAM MEDICAL PRACTICE LTD
STATEMENT OF FINANCIAL POSITION
31 July 2023
2023
2022
Note
£
£
£
£
FIXED ASSETS
Investments
4
100
100
CURRENT ASSETS
Debtors
5
16,650
16,650
CREDITORS: amounts falling due within one year
6
( 16,149)
( 16,149)
--------
--------
NET CURRENT ASSETS
501
501
----
----
TOTAL ASSETS LESS CURRENT LIABILITIES
601
601
----
----
NET ASSETS
601
601
----
----
CAPITAL AND RESERVES
Called up share capital
100
100
Profit and loss account
501
501
----
----
SHAREHOLDERS FUNDS
601
601
----
----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
The company did not trade during the current year or prior year and has not made either a profit or loss.
For the year ending 31 July 2023 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
FRANCIS LAM MEDICAL PRACTICE LTD
STATEMENT OF FINANCIAL POSITION (continued)
31 July 2023
These financial statements were approved by the board of directors and authorised for issue on 5 May 2024 , and are signed on behalf of the board by:
Mr F Lam
Director
Company registration number: 07135184
FRANCIS LAM MEDICAL PRACTICE LTD
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 31 JULY 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Lynton House, 7-12 Tavistock Square, London, WC1H 9BQ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Income statement
The company is dormant as defined by section 1169 of the Companies Act 2006. The company received no income and incurred no expenditure during the current year or prior year and therefore no income statement is presented within these financial statements. There have been no movements in shareholders funds during the current year or prior year.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.
4. Investments
Shares in group undertakings
£
Cost
At 1 August 2022 and 31 July 2023
100
----
Impairment
At 1 August 2022 and 31 July 2023
----
Carrying amount
At 31 July 2023
100
----
At 31 July 2022
100
----
5. Debtors
2023
2022
£
£
Amounts owed by group undertakings
15,509
15,509
Other debtors
1,141
1,141
--------
--------
16,650
16,650
--------
--------
6. Creditors: amounts falling due within one year
2023
2022
£
£
Other creditors
16,149
16,149
--------
--------
7. Related party transactions
The company has taken advantage of the exemption allowed under the Financial Reporting Standard 102 not to disclose related party transactions between wholly owned members of the same group of companies.